These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 28906259

  • 1. Radiation and Immunotherapy in High-grade Gliomas: Where Do We Stand?
    Reznik E, Smith AW, Taube S, Mann J, Yondorf MZ, Parashar B, Wernicke AG.
    Am J Clin Oncol; 2018 Feb; 41(2):197-212. PubMed ID: 28906259
    [Abstract] [Full Text] [Related]

  • 2. Glioblastoma multiforme: evidence-based approach to therapy.
    Nicholas MK.
    Expert Rev Anticancer Ther; 2007 Dec; 7(12 Suppl):S23-7. PubMed ID: 18076314
    [Abstract] [Full Text] [Related]

  • 3. A randomized controlled phase II trial of vaccination with lysate-loaded, mature dendritic cells integrated into standard radiochemotherapy of newly diagnosed glioblastoma (GlioVax): study protocol for a randomized controlled trial.
    Rapp M, Grauer OM, Kamp M, Sevens N, Zotz N, Sabel M, Sorg RV.
    Trials; 2018 May 25; 19(1):293. PubMed ID: 29801515
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Patterns of Care and Outcomes of Hypofractionated Chemoradiation Versus Conventionally Fractionated Chemoradiation for Glioblastoma in the Elderly Population.
    Haque W, Verma V, Butler EB, Teh BS.
    Am J Clin Oncol; 2018 Feb 25; 41(2):167-172. PubMed ID: 29369825
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Survival improvements with adjuvant therapy in patients with glioblastoma.
    Jayamanne D, Wheeler H, Cook R, Teo C, Brazier D, Schembri G, Kastelan M, Guo L, Back MF.
    ANZ J Surg; 2018 Mar 25; 88(3):196-201. PubMed ID: 28922698
    [Abstract] [Full Text] [Related]

  • 10. Phase I/IIa study of cilengitide and temozolomide with concomitant radiotherapy followed by cilengitide and temozolomide maintenance therapy in patients with newly diagnosed glioblastoma.
    Stupp R, Hegi ME, Neyns B, Goldbrunner R, Schlegel U, Clement PM, Grabenbauer GG, Ochsenbein AF, Simon M, Dietrich PY, Pietsch T, Hicking C, Tonn JC, Diserens AC, Pica A, Hermisson M, Krueger S, Picard M, Weller M.
    J Clin Oncol; 2010 Jun 01; 28(16):2712-8. PubMed ID: 20439646
    [Abstract] [Full Text] [Related]

  • 11. Phase I/IIa trial of fractionated radiotherapy, temozolomide, and autologous formalin-fixed tumor vaccine for newly diagnosed glioblastoma.
    Ishikawa E, Muragaki Y, Yamamoto T, Maruyama T, Tsuboi K, Ikuta S, Hashimoto K, Uemae Y, Ishihara T, Matsuda M, Matsutani M, Karasawa K, Nakazato Y, Abe T, Ohno T, Matsumura A.
    J Neurosurg; 2014 Sep 01; 121(3):543-53. PubMed ID: 24995786
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Systematic review and meta-analysis of phase I/II targeted therapy combined with radiotherapy in patients with glioblastoma multiforme: quality of report, toxicity, and survival.
    dos Santos MA, Pignon JP, Blanchard P, Lefeuvre D, Levy A, Touat M, Louvel G, Dhermain F, Soria JC, Deutsch E, Le Teuff G.
    J Neurooncol; 2015 Jun 01; 123(2):307-14. PubMed ID: 25975195
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Dendritic cell immunotherapy for glioblastoma.
    Polyzoidis S, Ashkan K.
    Expert Rev Anticancer Ther; 2014 Jul 01; 14(7):761-3. PubMed ID: 24850137
    [Abstract] [Full Text] [Related]

  • 17. Phase II trial of hypofractionated intensity-modulated radiation therapy combined with temozolomide and bevacizumab for patients with newly diagnosed glioblastoma.
    Ney DE, Carlson JA, Damek DM, Gaspar LE, Kavanagh BD, Kleinschmidt-DeMasters BK, Waziri AE, Lillehei KO, Reddy K, Chen C.
    J Neurooncol; 2015 Mar 01; 122(1):135-43. PubMed ID: 25524817
    [Abstract] [Full Text] [Related]

  • 18. Pseudoprogression in patients with glioblastoma multiforme after concurrent radiotherapy and temozolomide.
    Topkan E, Topuk S, Oymak E, Parlak C, Pehlivan B.
    Am J Clin Oncol; 2012 Jun 01; 35(3):284-9. PubMed ID: 21399487
    [Abstract] [Full Text] [Related]

  • 19. Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide.
    Stupp R, Dietrich PY, Ostermann Kraljevic S, Pica A, Maillard I, Maeder P, Meuli R, Janzer R, Pizzolato G, Miralbell R, Porchet F, Regli L, de Tribolet N, Mirimanoff RO, Leyvraz S.
    J Clin Oncol; 2002 Mar 01; 20(5):1375-82. PubMed ID: 11870182
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.